Guatemalan Standards Commission (COGUANOR) Mandatory Standard (NGO) / Central American Technical Regulation (RTCA) No. 75.01.21:05: Petroleum Products. Liquefied Petroleum Gases: Commercial Propane, Commercial Butane and Mixtures Thereof. Specifications (9 pages, in Spanish).
Distribution date: 15 July 2005 | Final date for Comment: 21 April 2025
Este reglamento técnico se debe aplicar al producto denominado Gas Licuado de Petróleo (GLP) que se comercializa en los países centroamericanos. Especifica las características físico químicas del Gas Licuado de Petróleo (GLP) para dos calidades: propano comercial y butano comercial, generalmente utilizados como combustible de calentamiento en el sector doméstico, comercial e industrial, como combustible automotriz y como materia prima para petroquímica. Se podrá utilizar cualquier mezcla de estos productos siempre que las mezclas cumplan con las especificaciones establecidas en este reglamento.
Products Covered: HS tariff heading 2711; International Classification for Standards (ICS) code 75.160.20
Regulation Type: Regular notification
Guatemalan Standards Commission (COGUANOR) Mandatory Standard (NGO) / Central American Technical Regulation (RTCA) No. 75.01.21:05: Petroleum Products. Liquefied Petroleum Gases: Commercial Propane, Commercial Butane and Mixtures Thereof. Specifications (9 pages, in Spanish).
Distribution date: 15 July 2005 | Final date for Comment: 21 April 2025
Este reglamento técnico se debe aplicar al producto denominado Gas Licuado de Petróleo (GLP) que se comercializa en los países centroamericanos. Especifica las características físico químicas del Gas Licuado de Petróleo (GLP) para dos calidades: propano comercial y butano comercial, generalmente utilizados como combustible de calentamiento en el sector doméstico, comercial e industrial, como combustible automotriz y como materia prima para petroquímica. Se podrá utilizar cualquier mezcla de estos productos siempre que las mezclas cumplan con las especificaciones establecidas en este reglamento.
Products Covered: HS tariff heading 2711; International Classification for Standards (ICS) code 75.160.20
Regulation Type: Regular notification
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph for Combination Drug Products (6 pages, in English).
Distribution date: 18 July 2005 | Final date for Comment: 21 April 2025
The Food and Drug Administration (FDA) is proposing to amend the tentative final monograph (TFM) for over-the-counter (OTC) cough-cold combination drug products to remove the combination of an oral bronchodilator (products containing ephedrine or its salts) and an expectorant, and to reclassify this combination drug product as Category II (not generally recognized as safe and effective for OTC use). FDA is also proposing to classify the combination of an oral bronchodilator and an oral nasal decongestant as Category II. FDA is issuing this notice of proposed rulemaking after considering data and information on the appropriateness of these combination drug products to treat mild asthma. Elsewhere in this issue of the Federal Register, FDA is proposing to amend the final monograph (FM) for OTC bronchodilator drug products to require additional labeling for all ingredients included in the FM. These proposed rules are part of FDA's ongoing review of OTC drug products.
Products Covered: Human Drug Products (HS Chapter 30; ICS 11.120)
Regulation Type: Regular notification
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph for Combination Drug Products (6 pages, in English).
Distribution date: 18 July 2005 | Final date for Comment: 21 April 2025
The Food and Drug Administration (FDA) is proposing to amend the tentative final monograph (TFM) for over-the-counter (OTC) cough-cold combination drug products to remove the combination of an oral bronchodilator (products containing ephedrine or its salts) and an expectorant, and to reclassify this combination drug product as Category II (not generally recognized as safe and effective for OTC use). FDA is also proposing to classify the combination of an oral bronchodilator and an oral nasal decongestant as Category II. FDA is issuing this notice of proposed rulemaking after considering data and information on the appropriateness of these combination drug products to treat mild asthma. Elsewhere in this issue of the Federal Register, FDA is proposing to amend the final monograph (FM) for OTC bronchodilator drug products to require additional labeling for all ingredients included in the FM. These proposed rules are part of FDA's ongoing review of OTC drug products.
Products Covered: Human Drug Products (HS Chapter 30; ICS 11.120)
Regulation Type: Regular notification
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of Monograph for Over-the-Counter Bronchodilator Drug Products (12 pages, in English).
Distribution date: 18 July 2005 | Final date for Comment: 21 April 2025
The Food and Drug Administration (FDA) is proposing to amend the final monograph (FM) for over-the-counter (OTC) bronchodilator drug products to add additional warnings (e.g., an "Asthma alert") and to revise the indications, warnings, and directions in the labeling of products containing the ingredients ephedrine, ephedrine hydrochloride, ephedrine sulfate, epinephrine, epinephrine bitartrate, racephedrine hydrochloride, and racepinephrine hydrochloride. This proposed rule is part of FDA's ongoing review of OTC drug products.
Products Covered: Human Drug Products (HS Chapter 30; ICS 11.120)
Regulation Type: Regular notification
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of Monograph for Over-the-Counter Bronchodilator Drug Products (12 pages, in English).
Distribution date: 18 July 2005 | Final date for Comment: 21 April 2025
The Food and Drug Administration (FDA) is proposing to amend the final monograph (FM) for over-the-counter (OTC) bronchodilator drug products to add additional warnings (e.g., an "Asthma alert") and to revise the indications, warnings, and directions in the labeling of products containing the ingredients ephedrine, ephedrine hydrochloride, ephedrine sulfate, epinephrine, epinephrine bitartrate, racephedrine hydrochloride, and racepinephrine hydrochloride. This proposed rule is part of FDA's ongoing review of OTC drug products.
Products Covered: Human Drug Products (HS Chapter 30; ICS 11.120)
Regulation Type: Regular notification
Pesticides; Procedural Regulations for Registration Review (25 pages, in English)
Distribution date: 18 July 2005 | Final date for Comment: 21 April 2025
The Food Quality Protection Act (FQPA) of 1996 amended the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) to require periodic review of pesticide registrations to ensure that over time they continue to meet statutory standards for registration. FIFRA section 3(g) specifies that EPA establish procedural regulations for conducting registration review and the goal of the regulations shall be Agency review of pesticide registrations on a 15 year cycle. This proposal describes the Agency's proposed approach to the registration review program. The proposed regulation is intended to ensure continued review of pesticides using procedures that provide for public participation and transparency in an efficient manner
Products Covered: Pesticides (HS Chapter: 3808; ICS: 13)
Regulation Type: Regular notification
Pesticides; Procedural Regulations for Registration Review (25 pages, in English)
Distribution date: 18 July 2005 | Final date for Comment: 21 April 2025
The Food Quality Protection Act (FQPA) of 1996 amended the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) to require periodic review of pesticide registrations to ensure that over time they continue to meet statutory standards for registration. FIFRA section 3(g) specifies that EPA establish procedural regulations for conducting registration review and the goal of the regulations shall be Agency review of pesticide registrations on a 15 year cycle. This proposal describes the Agency's proposed approach to the registration review program. The proposed regulation is intended to ensure continued review of pesticides using procedures that provide for public participation and transparency in an efficient manner
Products Covered: Pesticides (HS Chapter: 3808; ICS: 13)
Regulation Type: Regular notification
Technical regulations on fireworks and other pyrotechnic articles (52 pages, in Danish)
Distribution date: 09 August 2005 | Final date for Comment: 21 April 2025
Products Covered: Fireworks and other pyrotechnic articles
Regulation Type: Regular notification
Technical regulations on fireworks and other pyrotechnic articles (52 pages, in Danish)
Distribution date: 09 August 2005 | Final date for Comment: 21 April 2025
Products Covered: Fireworks and other pyrotechnic articles
Regulation Type: Regular notification
Submit your email ID to receive notifications about upcoming courses and events
